Moving epidemic method (MEM) applied to virology data as a novel real time tool to predict peak in seasonal influenza healthcare utilisation. The Scottish experience of the 2017/18 season to date by Murray, Josephine L K et al.
Murray, Josephine L K and Marques, Diogo F P and Cameron, Ross L 
and Potts, Alison and Bishop, Jennifer and von Wissmann, Beatrix and 
William, Naoma and Reynolds, Arlene J and Robertson, Chris and 
McMenamin, Jim (2018) Moving epidemic method (MEM) applied to 
virology data as a novel real time tool to predict peak in seasonal 
influenza healthcare utilisation. The Scottish experience of the 2017/18 
season to date. Eurosurveillance, 23 (11). pp. 1-5. ISSN 1025-496X , 
http://dx.doi.org/10.2807/1560-7917.ES.2018.23.11.18-00079
This version is available at https://strathprints.strath.ac.uk/63843/
Strathprints is  designed  to  allow  users  to  access  the  research  output  of  the  University  of 
Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights 
for the papers on this site are retained by the individual authors and/or other copyright owners. 
Please check the manuscript for details of any other licences that may have been applied. You 
may  not  engage  in  further  distribution  of  the  material  for  any  profitmaking  activities  or  any 
commercial gain. You may freely distribute both the url (https://strathprints.strath.ac.uk/) and the 
content of this paper for research or private study, educational, or not-for-profit purposes without 
prior permission or charge. 
Any correspondence concerning this service should be sent to the Strathprints administrator: 
strathprints@strath.ac.uk
The Strathprints institutional repository (https://strathprints.strath.ac.uk) is a digital archive of University of Strathclyde research 
outputs. It has been developed to disseminate open access research outputs, expose data about those outputs, and enable the 
management and persistent access to Strathclyde's intellectual output.
1www.eurosurveillance.org
Rapid communications
Moving epidemic method (MEM) applied to virology 
data as a novel real time tool to predict peak in seasonal 
inluenza healthcare utilisation. he Scottish experience 
of the 2017/18 season to date
Josephine L K Murray1, Diogo F P Marques1, Ross L Cameron1, Alison Potts2, Jennifer Bishop1, Beatrix von Wissmann3, Naoma 
William1, Arlene J Reynolds1, Chris Robertson1,4, Jim McMenamin1
1. Health Protection Scotland (HPS), Glasgow, United Kingdom
2. NHS Grampian, Aberdeen, United Kingdom
3. NHS Greater Glasgow & Clyde, Glasgow, United Kingdom
4. University of Strathclyde, Glasgow, United Kingdom
Correspondence: Josephine-L. K. Murray (josie.murray@nhs.net)
Citation style for this article: 
Murray Josephine L K, Marques Diogo F P, Cameron Ross L, Potts Alison, Bishop Jennifer, von Wissmann Beatrix, William Naoma, Reynolds Arlene J, Robertson Chris, 
McMenamin Jim. Moving epidemic method (MEM) applied to virology data as a novel real time tool to predict peak in seasonal inluenza healthcare utilisation. The 
Scottish experience of the 2017/18 season to date. Euro Surveill. 2018;23(11):pii=18-00079. https://doi.org/10.2807/1560-7917.ES.2018.23.11.18-00079 
Article submitted on 19 Feb 2018 / accepted on 15 Mar 2018 / published on 15 Mar 2018
Scotland observed an unusual influenza A(H3N2)-
dominated 2017/18 influenza season with healthcare 
services under significant pressure. We report the 
application of the moving epidemic method (MEM) to 
virology data as a tool to predict the influenza peak 
activity period and peak week of swab positivity in the 
current season. This novel MEM application has been 
successful locally and is believed to be of potential use 
to other countries for healthcare planning and building 
wider community resilience.
In December of 2017, influenza caused considerable 
strain on healthcare services. Due to reports that 
local healthcare systems were under substantial strain 
over the festive period, in calendar week 52, Health 
Protection Scotland was asked by the Scottish Chief 
Medical Officer to predict when influenza activity 
would peak in primary and secondary care. Such pre-
diction was sought to assist healthcare resilience plan-
ning within the context of managing pressures on the 
National Health Service in the winter [1].
Problem solving 
Methods to predict the time of peak influenza activity 
were considered. Formal influenza prediction modelling 
requires additional resource (time, money and statisti-
cal expertise) and the validity of output is uncertain. In 
time-pressured circumstances, this was deemed unfea-
sible. Use of previous seasons’ laboratory surveillance 
data to calculate the average number of weeks from 
start to peak of influenza laboratory detections was 
contemplated. This option was immediately achievable 
from existing laboratory surveillance data, required no 
extra funding and comparatively little extra computa-
tional time, and was therefore pursued.
Data sources 
We used two sources of laboratory surveillance data. 
The first was a primary care virology sentinel swabbing 
scheme that collates laboratory results of swabs taken 
from a representative sample of the population who 
present to primary care with influenza-like illness (ILI) 
[2]. The second was a secondary care electronic sys-
tem that collates data from all Scottish laboratories for 
pathogens including influenza [3]. Over 90% of all sam-
ples are submitted from patients presenting to hospi-
tal. Positive and negative test results for influenza are 
received from both schemes allowing the proportion of 
patients testing positive to be determined, i.e. swab 
positivity.
Defining the start of a season 
We used the moving epidemic method (MEM) [4] to 
define the epidemic threshold and identify the start of 
each influenza season. MEM is a standardised method 
of reporting influenza activity adopted by the European 
Centre for Disease Prevention and Control that allows 
intra- and inter- country comparisons [5]. MEM defines 
the baseline influenza activity in historical data and 
establishes an epidemic threshold above which the 
weekly rates are considered to be in the epidemic period. 
Based on the historical data, influenza activity inten-
sity is then also described according to categories as 
follows [6]: (i) baseline: weekly rate ≤ epidemic thresh-
old; (ii) low: epidemic threshold < weekly rate ≤ medium 
intensity threshold; (iii) medium: medium intensity 
threshold < weekly rate ≤ high intensity threshold; (iv) 
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high: high intensity threshold < weekly rate ≤ very high 
intensity threshold; (v) very high: weekly rate > very 
high intensity threshold.
To calculate the epidemic thresholds for the influenza 
season 2017/18 we used R [7] and swab positivity data 
from seasons 2010/11 to 2016/17.
The MEM epidemic threshold for the 2017/18 season 
(16.7% for primary care virology and 5.7% for second-
ary care virology) was applied retrospectively to each 
previous season. The start of a season was defined 
as the week where swab positivity was and remained 
above the epidemic threshold for two or more consecu-
tive weeks.
Estimations using the epi-viro proxy parameter 
(Goldstein indicator) [8] and ILI were conducted, how-
ever due to no/infrequent ILI MEM exceedances above 
baseline, in a number of influenza seasons considered 
in this work, results from this approach are not pre-
sented within the main study findings, but are avail-
able for comparison (Supplement).
Predicting the peak influenza activity 
period 
For each previous influenza season, using both primary 
and secondary care virology data, we calculated the 
week of breach of the epidemic threshold (a); the week 
of peak in swab positivity (b); the time to peak from 
breach of threshold in weeks, including the breach 
week ((b – a) + 1); and the proportion of positives by 
influenza type/subtype (Tables 1and 2). We estimated 
the predicted peak activity period as the average of 
the time to peak (in weeks) rounded to the nearest 
whole number, with a range of +/  −  1  week. As influ-
enza A(H3N2) was the predominant subtype of influ-
enza detected this season in Scotland, we estimated 
the average time to peak using data from the seasons 
where influenza A(H3N2) was the most prevalent influ-
enza subtype (three seasons for primary and four sea-
sons for secondary care virology).
Based on primary care virology data, the predicted 
average time to peak was 6 weeks and the start of the 
2017/18 season was in week 47, meaning that the pre-
dicted peak activity period would be between week 51 
and week  01. Based on secondary care virology data, 
Figure 1
Primary care swab influenza positivity data, moving 
epidemic method thresholds and predicted peak activity 
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Figure 2
Secondary care swab positivity data, moving epidemic 
method thresholds and predicted peak activity period for 
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the predicted average time to peak was 5  weeks and 
start of the 2017/18 season was also in week 47, mean-
ing that the predicted peak activity period would be 
between weeks 50 and 52.
These predictions aligned with subsequent swab posi-
tivity observations in the 2017/18 influenza season for 
both primary and secondary care. The observed time to 
peak in primary care was 5 weeks, and observed time 
to peak in secondary care was 6  weeks, where peaks 




Understanding the timing of peak seasonal influenza 
activity is important to Governments, Ministries of 
Health and resilience planners to inform public health 
decision making and resource allocation for healthcare 
system pressures each winter. We propose that the 
MEM applied to routine virology data may provide a 
useful tool to define the start of the influenza season 
and predict the influenza peak activity period.
There are obvious limitations to this predictive 
approach. First, to our knowledge, no other country 
has used this prediction of peak activity before, so we 
Table 1
Observed primary care virology dataa by influenza season in Scotland, 2010/11–2017/18
Season
Week of breach of baseline 
threshold (> 16.7%) 
 
(a)




Time to peak 
in weeks 
 
((b - a) + 1)







2010/11 48 52 5 51 1 1 47
2011/12 8 11 4 1 84 5 11
2012/13 50 5 8 8 29 2 61
2013/14 5 10 6 84 8 3 5
2014/15 52 5 6 4 67 4 25
2015/16 3 9 7 59 1 2 38
2016/17 50 4 7 < 1 57 10 32
2017/18 47 51 5 2 64 6 29
Seasons with influenza A(H3N2) as the most prevalent subtype are highlighted in light blue for those seasons used to predict peak activity for 
2017/18.
a Primary care virology data refer to data from a primary care virology sentinel swabbing scheme that collates laboratory results of swabs 
taken from a representative sample of the population who present to primary care with influenza-like illness (ILI).
Table 2
Observed secondary care virology dataa by influenza season in Scotland, 2010/11–2017/18
Season
Week of breach of baseline 
threshold (> 5.7%) 
 
(a)




Time to peak in 
weeks 
 
((b - a) + 1)






2010/11 50 52 3 68 < 1 3 29
2011/12 8 11 4 1 63 27 9
2012/13 50 52 3 10 49 3 38
2013/14 5 7 3 81 13 3 3
2014/15 51 6 8 2 67 11 20
2015/16 52 10 11 62 2 7 29
2016/17 50 1 4 1 61 13 25
2017/18 47 52 6 2 55 24 19
Seasons with influenza A(H3N2) as the most prevalent subtype are highlighted in light blue for those seasons used to predict peak activity for 
2017/18.
a Secondary care virology data refer to data from a secondary care electronic system that collates data from all Scottish laboratories for 
pathogens including influenza. Over 90% of all samples are submitted from patients presenting to hospital.
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have no means to benchmark our work. Second, we 
have not predicted the severity of the season to come, 
however we look forward to output from World Health 
Organization Pandemic Influenza Severity Assessment 
(PISA) project [9] and others on this matter.
Third, we were unable to calculate retrospective sea-
son-specific MEM thresholds due to lack of available 
data before season 2010/11. The retrospective appli-
cation of 2017/18 thresholds was used as a pragmatic 
approach and believed to be accurate due to the small 
variation between epidemic thresholds in recent sea-
sons (Supplement).
Fourth, laboratory data are affected by reporting delay, 
especially during festive periods, which may affect 
the ability to timely detect the start of the season. 
Repeated predictions would account for this when 
more data become available.
We are mindful that our vaccine uptake, the effective-
ness of the vaccine and the public health impact of 
the influenza vaccination programme will play a role 
in mitigating our current influenza season [10,11], how-
ever, the precise impact is unknown. It is important to 
consider this when further validating the usefulness of 
the above method.
The strength of this approach is its relative low time 
and data requirements, which allow a quick and simple 
estimation of the likely peak influenza activity period. 
This was possible due to the fact that Scotland has a 
well-established, comprehensive, representative and 
timely influenza surveillance system with enough ret-
rospective electronic data available to allow applica-
tion of the MEM methodology.
In this study, while applying the Goldstein indicator 
was considered (Supplement), there were two influ-
enza seasons (2011/12 and 2013/14) where this was 
not possible because the data only breached the epi-
demic threshold in one and two weeks, respectively. 
There was moreover a similar limitation for ILI – in both 
the influenza seasons 2011/12, 2013/14, ILI did not 
breach the MEM threshold. Indeed, since the success-
ful introduction of the live adapted intranasal influenza 
vaccine (LAIV) in children (LAIV vaccine uptake ≥50% 
in pre-school children and ≥70% in primary school age 
children) in Scotland [12] we have observed no/infre-
quent ILI MEM exceedances above baseline (2014/15, 
2015/16, 2016/17). A pragmatic approach was therefore 
to use the best available data, consisting of swab posi-
tivity data from our general practice sentinel swabbing 
scheme.
Due to the pragmatic nature of our methods, our predic-
tion was used in real time, and at short notice to inform 
resource planning to ensure the population healthcare 
system continued to function amid challenges posed 
by influenza. Furthermore, as this approach did not 
require significant additional resource, we believe this 
low-cost method could be applied widely.
This MEM approach made two key assumptions. Firstly, 
that the pattern from the past would be indicative of 
the pattern that we would see in the current season. 
Secondly, that timing would be the same in all influ-
enza seasons where influenza A(H3N2) was the most 
prevalent subtype.
We also tested the hypothesis that the timing would 
be the same regardless of influenza subtype by using 
all influenza seasons data (data not shown). This did 
not change the weeks predicted, therefore we cannot 
be certain whether the most prevalent subtype of influ-
enza plays any role in prediction. This may suggest that 
our approach could be useful for planning regardless of 
the seasonal dominant influenza subtype.
Next steps
Further work examining the usefulness of MEM for sea-
sons dominated by other influenza types or the influ-
ence of co-dominance of influenza type/subtype needs 
to be undertaken. Similarly, the application of season-
specific MEM thresholds should be attempted in the 
future.
We have written this rapid communication to allow col-
leagues in other countries to explore the usefulness of 
applying the same methodology to predict peak influ-
enza activity in their countries. This may allow them 
to inform resilience planning and policy for healthcare 
systems to respond effectively to winter pressures. We 
look forward to their findings.
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